Medicare has quietly drawn a line from healthcare policy to artificial intelligence, creating a payment path for the kind of patient support that often happens long after a clinic visit ends.
The change centers on ACCESS, a new payment model that addresses a longstanding gap in the system: Medicare has not had a clear way to pay for an AI agent or similar tool that monitors a patient between visits, checks in by phone, helps coordinate a housing referral, or nudges someone to pick up medication. That gap has limited adoption of tools that promise to manage risk outside the exam room, even as startups and health systems invest heavily in them.
ACCESS matters because it turns a technical possibility into a reimbursable service — and in healthcare, payment often decides what scales.
The significance reaches beyond billing. Reports indicate the model could give healthcare organizations a reason to deploy AI where it may have the most practical value: routine follow-up, coordination, and continuity of care. Those tasks rarely generate headlines, but they shape whether patients stay on treatment, avoid preventable crises, and get connected to services that affect health outcomes. Until now, many of those activities sat in a financial gray zone.
Key Facts
- ACCESS creates a Medicare payment mechanism for care support delivered between visits.
- The model could cover functions such as monitoring, check-ins, medication follow-up, and referral coordination.
- Medicare previously lacked a clear way to reimburse an AI agent for this kind of work.
- The policy shift may accelerate adoption of healthcare AI in operational, patient-facing settings.
That helps explain why the development could land with unusual force. Much of the tech world tends to focus on model performance, consumer apps, or hospital workflow software. Medicare reimbursement operates on a different layer of power. When the government defines what it will pay for, entrepreneurs, providers, and investors often reorganize around that signal. Sources suggest many outside healthcare still underestimate how quickly that can change product strategy.
What comes next will depend on how providers interpret the model, how regulators oversee its use, and whether AI tools can prove they improve care without adding confusion or waste. But the direction looks clear: if Medicare starts paying for between-visit support, companies building AI for healthcare may stop chasing novelty and start building for the unglamorous work that keeps patients connected to care.